4//SEC Filing
COUGHLIN TIMOTHY 4
Accession 0001209191-23-030958
CIK 0001438533other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:05 PM ET
Size
7.4 KB
Accession
0001209191-23-030958
Insider Transaction Report
Form 4
Coughlin Timothy P
Director
Transactions
- Award
Common Stock
2023-05-17+4,500→ 42,500 total - Award
Stock option (right to buy)
2023-05-17+13,500→ 13,500 totalExercise: $17.11From: 2024-05-17Exp: 2033-05-16→ Common Stock (13,500 underlying)
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001376043
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:05 PM ET
- Size
- 7.4 KB